Literature DB >> 16568343

Screening for polymorphisms in the PXR gene in a Dutch population.

Tessa M Bosch1, Maarten Deenen, Roelof Pruntel, Paul H M Smits, Jan H M Schellens, Jos H Beijnen, Irma Meijerman.   

Abstract

OBJECTIVE: Cytochrome P450 3A4 (CYP3A4) is involved in the metabolism of over 50% of all drugs currently in use. However, CYP3A4 expression shows a large inter-individual variation that cannot only be explained by genetic polymorphisms identified in this gene. The pregnane X receptor (PXR) has been identified as a transcriptional regulator of CYP3A4. Single nucleotide polymorphisms (SNPs) in the PXR gene could influence PXR activity and thereby CYP3A4 expression. This study was therefore aimed at determining the frequencies of known SNPs and detecting yet unknown SNPs in the PXR gene in a Dutch population.
METHODS: Genomic DNA was isolated from blood samples obtained from 100 healthy volunteers and subjected to PCR amplification, followed by DNA sequencing. The population, of which the ethnicity was 93% Caucasian, consisted of 79 female individuals and 21 males.
RESULTS: A total of 24 SNPs were found in the PXR gene, eight of which are previously unknown. The allelic frequencies found in this population varied from 0.5 to 73%. Most of the previously detected SNPs were located in introns. One new SNP, T8555G in exon 8, causes an amino acid change of C379G and is located in the Ligand Binding Domain of PXR.
CONCLUSION: Several SNPs were detected in the PXR gene, one of which is located in the ligand binding domain (LBD). These SNPs may influence PXR-mediated CYP3A4 induction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16568343     DOI: 10.1007/s00228-006-0108-0

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  10 in total

1.  Rapid and simple method for purification of nucleic acids.

Authors:  R Boom; C J Sol; M M Salimans; C L Jansen; P M Wertheim-van Dillen; J van der Noordaa
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

2.  The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants.

Authors:  J Zhang; P Kuehl; E D Green; J W Touchman; P B Watkins; A Daly; S D Hall; P Maurel; M Relling; C Brimer; K Yasuda; S A Wrighton; M Hancock; R B Kim; S Strom; K Thummel; C G Russell; J R Hudson; E G Schuetz; M S Boguski
Journal:  Pharmacogenetics       Date:  2001-10

3.  CYP3A4 variant alleles in white individuals with low CYP3A4 enzyme activity.

Authors:  Elena García-Martín; Carmen Martínez; Rosa M Pizarro; Francisco J García-Gamito; Harriet Gullsten; Hannu Raunio; José A G Agúndez
Journal:  Clin Pharmacol Ther       Date:  2002-03       Impact factor: 6.875

4.  Identification of the novel splicing variants for the hPXR in human livers.

Authors:  Shuichi Fukuen; Tsuyoshi Fukuda; Hideyasu Matsuda; Akihiko Sumida; Isamu Yamamoto; Tadanobu Inaba; Junichi Azuma
Journal:  Biochem Biophys Res Commun       Date:  2002-11-01       Impact factor: 3.575

5.  Factors affecting cytochrome P-450 3A activity in cancer patients.

Authors:  Sharyn D Baker; Ron H N van Schaik; Laurent P Rivory; Albert J Ten Tije; Kimberly Dinh; Wilfried J Graveland; Paul W Schenk; Kellie A Charles; Stephen J Clarke; Michael A Carducci; William P McGuire; Fitzroy Dawkins; Hans Gelderblom; Jaap Verweij; Alex Sparreboom
Journal:  Clin Cancer Res       Date:  2004-12-15       Impact factor: 12.531

6.  Natural protein variants of pregnane X receptor with altered transactivation activity toward CYP3A4.

Authors:  E Hustert; A Zibat; E Presecan-Siedel; R Eiselt; R Mueller; C Fuss; I Brehm; U Brinkmann; M Eichelbaum; L Wojnowski; O Burk
Journal:  Drug Metab Dispos       Date:  2001-11       Impact factor: 3.922

7.  The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions.

Authors:  J M Lehmann; D D McKee; M A Watson; T M Willson; J T Moore; S A Kliewer
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

8.  SXR, a novel steroid and xenobiotic-sensing nuclear receptor.

Authors:  B Blumberg; W Sabbagh; H Juguilon; J Bolado; C M van Meter; E S Ong; R M Evans
Journal:  Genes Dev       Date:  1998-10-15       Impact factor: 11.361

9.  PXR (NR1I2): splice variants in human tissues, including brain, and identification of neurosteroids and nicotine as PXR activators.

Authors:  Vishal Lamba; Kazuto Yasuda; Jatinder K Lamba; Mahfoud Assem; Julio Davila; Stephen Strom; Erin G Schuetz
Journal:  Toxicol Appl Pharmacol       Date:  2004-09-15       Impact factor: 4.219

10.  Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction.

Authors:  G Bertilsson; J Heidrich; K Svensson; M Asman; L Jendeberg; M Sydow-Bäckman; R Ohlsson; H Postlind; P Blomquist; A Berkenstam
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

  10 in total
  9 in total

1.  Genetic polymorphisms of pharmacogenomic VIP variants in the lhoba population of southwest China.

Authors:  Yongjun He; Hua Yang; Tingting Geng; Tian Feng; Dongya Yuan; Longli Kang; Manling Luo; Tianbo Jin
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

2.  Identification of NR1I2 genetic variation using resequencing.

Authors:  Cristi R King; Ming Xiao; Jinsheng Yu; Matthew R Minton; Nicholas J Addleman; Derek J Van Booven; Pui-Yan Kwok; Howard L McLeod; Sharon Marsh
Journal:  Eur J Clin Pharmacol       Date:  2007-04-03       Impact factor: 2.953

3.  PXR variants and artemisinin use in Vietnamese subjects: frequency distribution and impact on the interindividual variability of CYP3A induction by artemisinin.

Authors:  Rita Piedade; Elke Schaeffeler; Stefan Winter; Sara Asimus; Matthias Schwab; Michael Ashton; Oliver Burk; José P Gil
Journal:  Antimicrob Agents Chemother       Date:  2012-01-17       Impact factor: 5.191

4.  Identification of polymorphisms in the 3'-untranslated region of the human pregnane X receptor (PXR) gene associated with variability in cytochrome P450 3A (CYP3A) metabolism.

Authors:  L Oleson; L L von Moltke; D J Greenblatt; M H Court
Journal:  Xenobiotica       Date:  2010-02       Impact factor: 1.908

5.  Pregnane X Receptor (PXR) expression in colorectal cancer cells restricts irinotecan chemosensitivity through enhanced SN-38 glucuronidation.

Authors:  Caroline Raynal; Jean-Marc Pascussi; Géraldine Leguelinel; Cyril Breuker; Jovana Kantar; Benjamin Lallemant; Sylvain Poujol; Caroline Bonnans; Dominique Joubert; Frédéric Hollande; Serge Lumbroso; Jean-Paul Brouillet; Alexandre Evrard
Journal:  Mol Cancer       Date:  2010-03-02       Impact factor: 27.401

6.  Expression, localization and polymorphisms of the nuclear receptor PXR in Barrett's esophagus and esophageal adenocarcinoma.

Authors:  Anouk van de Winkel; Vivianda Menke; Astrid Capello; Leon M G Moons; Raymond G J Pot; Herman van Dekken; Peter D Siersema; Johannes G Kusters; Luc J W van der Laan; Ernst J Kuipers
Journal:  BMC Gastroenterol       Date:  2011-10-06       Impact factor: 3.067

7.  Genetic analysis of pharmacogenomic VIP variants in the Blang population from Yunnan Province of China.

Authors:  Chan Zhang; Weiwei Guo; Yujing Cheng; Qi Li; Xin Yang; Run Dai; Linhao Zhu; Wanlu Chen
Journal:  Mol Genet Genomic Med       Date:  2019-04-05       Impact factor: 2.183

8.  Top Three Pharmacogenomics and Personalized Medicine Applications at the Nexus of Renal Pathophysiology and Cardiovascular Medicine.

Authors:  Murielle Bochud; Michel Burnier; Idris Guessous
Journal:  Curr Pharmacogenomics Person Med       Date:  2011-12

Review 9.  The steroid and xenobiotic receptor (SXR), beyond xenobiotic metabolism.

Authors:  Changcheng Zhou; Suman Verma; Bruce Blumberg
Journal:  Nucl Recept Signal       Date:  2009-01-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.